Exploring the Genetic Architecture of Brugada Syndrome with Genomic Methods
Connie Bezzina, Professor of Molecular Cardiogenetics at the Academic Medical Center at the University of Amsterdam, presents data from her laboratory and shares ongoing collaborative studies with the international Brugada Syndrome Genetics Consortium. In this webinar, she describes the complex genetic basis of inherited cardiac rhythm disorders and variability in disease severity among carriers of disease-causing variants. These recent advances were achieved using multiple genomic methods, including genome-wide association studies (GWAS) and whole-genome sequencing (WGS). To learn more about solutions for complex disease research, visit https://www.illumina.com/areas-of-interest/complex-disease-genomics.html A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM
Connie Bezzina, Professor of Molecular Cardiogenetics at the Academic Medical Center at the University of Amsterdam, presents data from her laboratory and shares ongoing collaborative studies with the international Brugada Syndrome Genetics Consortium. In this webinar, she describes the complex genetic basis of inherited cardiac rhythm disorders and variability in disease severity among carriers of disease-causing variants. These recent advances were achieved using multiple genomic methods, including genome-wide association studies (GWAS) and whole-genome sequencing (WGS). To learn more about solutions for complex disease research, visit https://www.illumina.com/areas-of-interest/complex-disease-genomics.html A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM